150 related articles for article (PubMed ID: 21486958)
1. Antimalarial effects of human immunodeficiency virus protease inhibitors in rhesus macaques.
Li Y; Qin L; Peng N; Liu G; Zhao S; He Z; Chen X
Antimicrob Agents Chemother; 2011 Jun; 55(6):3039-42. PubMed ID: 21486958
[TBL] [Abstract][Full Text] [Related]
2. Ritonavir-boosted indinavir but not lopinavir inhibits erythrocytic stage Plasmodium knowlesi malaria in rhesus macaques.
Qin L; Qin L; Xu W; Zhao S; Chen X
Bioorg Med Chem Lett; 2015 Apr; 25(7):1538-40. PubMed ID: 25704890
[TBL] [Abstract][Full Text] [Related]
3. Antiretrovirals as antimalarial agents.
Skinner-Adams TS; McCarthy JS; Gardiner DL; Hilton PM; Andrews KT
J Infect Dis; 2004 Dec; 190(11):1998-2000. PubMed ID: 15529265
[TBL] [Abstract][Full Text] [Related]
4. Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro.
Merrill DP; Manion DJ; Chou TC; Hirsch MS
J Infect Dis; 1997 Jul; 176(1):265-8. PubMed ID: 9207379
[TBL] [Abstract][Full Text] [Related]
5. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
[TBL] [Abstract][Full Text] [Related]
6. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.
Korting HC; Schaller M; Eder G; Hamm G; Böhmer U; Hube B
Antimicrob Agents Chemother; 1999 Aug; 43(8):2038-42. PubMed ID: 10428932
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo culture of Plasmodium vivax and Plasmodium cynomolgi and in vitro culture of Plasmodium knowlesi blood stages.
Zeeman AM; der Wel AV; Kocken CH
Methods Mol Biol; 2013; 923():35-49. PubMed ID: 22990770
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir.
Hoetelmans RM; Meenhorst PL; Mulder JW; Burger DM; Koks CH; Beijnen JH
Pharm World Sci; 1997 Aug; 19(4):159-75. PubMed ID: 9297727
[TBL] [Abstract][Full Text] [Related]
9. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes.
Inaba T; Fischer NE; Riddick DS; Stewart DJ; Hidaka T
Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.
Skinner-Adams TS; Andrews KT; Melville L; McCarthy J; Gardiner DL
Antimicrob Agents Chemother; 2007 Feb; 51(2):759-62. PubMed ID: 17088482
[TBL] [Abstract][Full Text] [Related]
11. Intracellular concentration of the HIV protease inhibitors indinavir and saquinavir in human endothelial cells.
Armbruster C; Vorbach H; Steindl F; El Menyawi I
J Antimicrob Chemother; 2001 Apr; 47(4):487-90. PubMed ID: 11266428
[TBL] [Abstract][Full Text] [Related]
12. Susceptibilities of simian immunodeficiency virus to protease inhibitors.
Giuffre AC; Higgins J; Buckheit RW; North TW
Antimicrob Agents Chemother; 2003 May; 47(5):1756-9. PubMed ID: 12709355
[TBL] [Abstract][Full Text] [Related]
13. Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo.
Li X; He Z; Chen L; Li Y; Li Q; Zhao S; Tao Z; Hu W; Qin L; Chen X
Parasitol Res; 2011 Dec; 109(6):1519-24. PubMed ID: 21537980
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
Schütt M; Zhou J; Meier M; Klein HH
J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of indinavir and saquinavir confirmed.
Bartnof HS
BETA; 1997 Sep; ():45. PubMed ID: 11364702
[TBL] [Abstract][Full Text] [Related]
16. Antileishmanial activity of HIV protease inhibitors.
Savoia D; Allice T; Tovo PA
Int J Antimicrob Agents; 2005 Jul; 26(1):92-4. PubMed ID: 15955671
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii.
Atzori C; Angeli E; Mainini A; Agostoni F; Micheli V; Cargnel A
J Infect Dis; 2000 May; 181(5):1629-34. PubMed ID: 10823762
[TBL] [Abstract][Full Text] [Related]
18. HIV protease inhibitors.
Carr A; Cooper DA
AIDS; 1996; 10 Suppl A():S151-7. PubMed ID: 8883623
[No Abstract] [Full Text] [Related]
19. Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir.
Pfister M; Labbé L; Lu JF; Hammer SM; Mellors J; Bennett KK; Rosenkranz S; Sheiner LB;
Clin Pharmacol Ther; 2002 Aug; 72(2):133-41. PubMed ID: 12189360
[TBL] [Abstract][Full Text] [Related]
20. Resistance to human immunodeficiency virus type 1 protease inhibitors.
Boden D; Markowitz M
Antimicrob Agents Chemother; 1998 Nov; 42(11):2775-83. PubMed ID: 9797203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
